KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd
's wholly-owned subsidiary MGRC Therapeutics Sdn Bhd has entered into a collaboration with South Korea-listed Dx&Vx Co Ltd to drive the development and supply of advanced genomic testing services.
It said MGRC Therapeutics will leverage its extensive expertise in genomics and biopharmaceuticals to support the operational and technical aspects of the genomic testing services.
